Consistent with this hypothesis, Fusco et al. found that although D2R mRNA was the predominant receptor among all tumor tissues studied, mean D2R mRNA levels were significantly lower in DA-resistant tumors than in DA-sensitive tumors [8]. This evidence concerns the gene DRD2 and neoplasm.